More about Aromatic L-Amino Acid Decarboxylase Deficiency
Infants with AADC deficiency typically show signs within the first 6 months of life, starting with feeding difficulties and low muscle tone. As they grow, they develop characteristic oculogyric crises (involuntary upward-rolling eye movements), severe developmental delays, and progressive movement disorders. Many also experience significant autonomic dysfunction, including excessive sweating, difficulty regulating body temperature, and blood pressure fluctuations.
Keep reading about Aromatic L-Amino Acid Decarboxylase Deficiency
Diagnosis involves genetic testing for DDC gene variants and cerebrospinal fluid analysis showing abnormal neurotransmitter levels. A major breakthrough came with FDA accelerated approval of Kebilidi (eladocagene exuparvovec-tneq) in November 2024, a gene therapy that delivers a healthy copy of the DDC gene directly into the brain.
What are the symptoms of Aromatic L-Amino Acid Decarboxylase Deficiency?
These are common symptoms of Aromatic L-Amino Acid Decarboxylase Deficiency, and how strong they are varies from person to person.
- Low muscle tone (hypotonia) and poor feeding
- Involuntary upward-rolling eye movements (oculogyric crises)
- Developmental delays and intellectual disability
- Movement disorders including dystonia
- Autonomic dysfunction: excessive sweating, temperature instability, drooping eyelids
- Sleep disturbances and mood changes including irritability
Who gets Aromatic L-Amino Acid Decarboxylase Deficiency?
AADC deficiency typically appears in infancy, with symptoms emerging within the first 6 months of life. The condition follows autosomal recessive inheritance, meaning both parents must carry a variant in the DDC gene. It affects males and females equally and is more prevalent in people of Asian descent, particularly those with ancestry from Taiwan, Japan, and China.
Next steps: find trials you might fitsee approved treatmentsget help payingget alerts
Which medicines are FDA-approved for Aromatic L-Amino Acid Decarboxylase Deficiency?
There is currently 1 FDA-approved medication for Aromatic L-Amino Acid Decarboxylase Deficiency.
Source: openFDA drug labeling data. This list may not include all treatments. Always consult your doctor.
How to get help paying for Aromatic L-Amino Acid Decarboxylase Deficiency treatment
Charity funds and drugmaker programs for Aromatic L-Amino Acid Decarboxylase Deficiency, checked at the source.
Side effects people have reported to the FDA
Side effects people have reported to the FDA
Real-world side effect reports from the FDA Adverse Event Reporting System (FAERS). Includes both FDA-approved drugs and investigational therapies from active clinical trials. Click any drug to see what patients reported.
Loading side effect data...
Diagnosis and genetic testing
Genetic testing for Aromatic L-Amino Acid Decarboxylase Deficiency
Genetic testing can confirm a diagnosis, guide treatment decisions, and identify family members who may be at risk.
Finding labs...
Trusted Aromatic L-Amino Acid Decarboxylase Deficiency resources
Reputable organizations and medical references for learning more about Aromatic L-Amino Acid Decarboxylase Deficiency, including disease registries, foundation resources, and clinical guidelines.